Literature DB >> 16893400

Penile duplex pharmaco-ultrasonography of cavernous arteries in men with erectile dysfunction and generalized atherosclerosis.

Massimo Bocchio1, Piero Scarpelli, Stefano Necozione, Fiore Pelliccione, Carlo Spartera, Felice Francavilla, Sandro Francavilla.   

Abstract

Assessment of cavernosal perfusion in men with erectile dysfunction (ED) relies on Doppler spectrum analysis of pharmachologically stimulated peak systolic velocity (sPSV) in cavernous arteries but its accuracy in identifying men affected by a cavernosal perfusion disorder correlated with atherosclerosis remains undefined. We estimated by B-mode ultrasound, the accuracy of sPSV of cavernous arteries to identify ED with an expected cavernosal perfusion disorder. This was predicted by an elevated intima-media thickness (IMT) of common carotid arteries, a reference methodology to estimate the degree of generalized atherosclerosis, in men exposed to vascular risk factors (VRFs). sPSV and IMT were evaluated in 269 men with ED, 49 had no VRFs, 100 were overweight with/or without hyperlipidaemia, 120 were affected by type 2 diabetes and/or essential hypertension. sPSV was significantly lower (p<0.05) in patients with VRFs associated with atherosclerosis (IMT>or=1 mm) (n=39) than in men with no VRFs and no atherosclerosis (n=49). sPSV correlated negatively with age (p<0.0001), with serum% of glycated haemoglobin (p=0.010) and with carotid artery IMT (p=0.013). An sPSV<or=30 cm/sec, the cut-off value which showed at receiver operating characteristic curve analysis the combined highest value of sensitivity and specificity, correctly identified only 57% of men in whom a cavernosal perfusion disorder was expected based on the presence of carotid artery IMT>or=1 mm combined to the exposure to VRFs. The ultrasonographic evaluation of sPSV had a very limited accuracy in discriminating ED with an expected cavernosal perfusion disorder, based on the presence of a generalized atherosclerosis in men with VRFs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893400     DOI: 10.1111/j.1365-2605.2006.00688.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  3 in total

Review 1.  The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016-2021).

Authors:  Mohammed Monirul Islam; Nimbagal Raghavendra Naveen; Posina Anitha; Prakash S Goudanavar; G S N Koteswara Rao; Santosh Fattepur; Muhammad Muhitur Rahman; Predeepkumar Narayanappa Shiroorkar; Mohammed Habeebuddin; Girish Meravanige; Mallikarjun Telsang; Sreeharsha Nagaraja; Syed Mohammed Basheeruddin Asdaq; M D Khalid Anwer
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment.

Authors:  Valter Javaroni; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-05-09       Impact factor: 2.420

3.  Characterization of age-related penile microvascular hemodynamic impairment using laser speckle contrast imaging: possible role of increased fibrogenesis.

Authors:  Seung-Ryeol Lee; Ki-Ho Kim; Ho-Song You; Johnny Fu; Tung-Chin Mike Hsieh; Valmik Bhargava; M Raj Rajasekaran
Journal:  Physiol Rep       Date:  2017-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.